[
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not provide the expiration date of the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. It only includes the parties involved and the date the agreement was dated (May 8, 2014). Therefore, there is no information available regarding the expiration date of the contract.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the renewal term for this contract?",
        "response":"The retrieved chunk does not provide any information regarding the renewal term for the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. Therefore, I cannot answer your question based on the provided clause.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the notice period required to terminate the renewal?",
        "response":"The retrieved chunk does not provide any specific information regarding the notice period required to terminate the renewal of the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. Therefore, I cannot provide an answer to your question based on the provided text.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the governing law for this contract?",
        "response":"The retrieved chunk does not specify the governing law for the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. Therefore, I cannot provide a direct answer regarding the governing law for this contract based on the provided information.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there an anti-assignment clause in this contract?",
        "response":"The provided chunk does not contain any specific information regarding an anti-assignment clause in the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. The text only includes the title of the agreement and the parties involved, along with the date, but does not provide any details about the terms, conditions, or restrictions, including whether an anti-assignment clause exists. Therefore, I cannot confirm the presence of such a clause based on the information given.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there a minimum commitment required under this contract?",
        "response":"The provided clause does not specify any minimum commitment required under the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. It only outlines the parties involved and their respective business addresses. Therefore, based on the information in the clause, there is no mention of a minimum commitment requirement.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What licenses are granted under this contract?",
        "response":"The retrieved chunk does not provide specific information regarding the licenses granted under the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. The text only includes the title of the agreement and the parties involved, without detailing any terms, conditions, or restrictions related to licenses. Therefore, I cannot provide an answer regarding the licenses granted under this contract based on the provided information.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What are the audit rights under this contract?",
        "response":"The provided chunk does not contain any information regarding the audit rights under the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. Therefore, I cannot provide an answer regarding the audit rights as it is not stated in the clause.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there a cap on liability under this contract?",
        "response":"The provided clause does not contain any information regarding a cap on liability under the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. Therefore, based on the retrieved chunk, there is no mention of any limitations or caps on liability in this contract.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the duration of any warranties provided in this contract?",
        "response":"The retrieved chunk does not provide any specific information regarding the duration of warranties in the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. Therefore, I cannot provide an answer to your question based on the available text.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the expiration date of this contract?",
        "response":"The provided clause does not specify an expiration date for the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. It only mentions the \"Effective Date\" as July 11, 2006. Therefore, without additional information or clauses indicating a duration or expiration, I cannot provide a specific expiration date for this contract.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the renewal term for this contract?",
        "response":"The provided clause does not specify the renewal term for the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. Therefore, I cannot provide an answer regarding the renewal term as it is not stated in the retrieved chunk.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the notice period required to terminate the renewal?",
        "response":"The notice period required to terminate the renewal of the Video-on-Demand Content License Agreement is sixty (60) days. This is specified in the clause, which states that \"each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended.\"",
        "retrieved_contexts":[
            ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. Therefore, based on the information available in the retrieved chunk, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a most favored nation clause in this contract?",
        "response":"The provided clause does not contain any information regarding a most favored nation clause in the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. The excerpt only identifies the parties involved and the effective date of the agreement, without detailing any specific terms, conditions, or clauses such as a most favored nation provision. Therefore, based on the retrieved chunk, I cannot confirm the presence of a most favored nation clause in this contract.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Can this contract be terminated for convenience, and under what conditions?",
        "response":"The provided clause does not include any information regarding the termination for convenience of the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. Therefore, based on the retrieved chunk, it is unclear whether the contract can be terminated for convenience or under what conditions. No specific terms or conditions related to termination for convenience are mentioned in the excerpt.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there an anti-assignment clause in this contract?",
        "response":"The provided clause does not contain any information regarding an anti-assignment clause in the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. Therefore, I cannot confirm whether such a clause exists based on the retrieved chunk. If you have access to additional sections of the agreement, I can help analyze those for relevant details.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not mention any revenue or profit-sharing arrangements between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. It only states the parties involved and the effective date of the Video-on-Demand Content License Agreement. Therefore, based on the information in the clause, there is no indication of any revenue or profit-sharing terms included in this contract.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a minimum commitment required under this contract?",
        "response":"The provided clause does not specify any details regarding a minimum commitment required under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. Therefore, based on the information available in the clause, there is no direct answer to your question about minimum commitment requirements.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What licenses are granted under this contract?",
        "response":"The retrieved chunk does not provide specific details about the licenses granted under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. It only identifies the parties involved and the effective date of the agreement. Therefore, I cannot provide information regarding the specific licenses granted under this contract based on the provided text.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Does this contract include an unlimited or all-you-can-eat license?",
        "response":"The provided clause does not specify whether the Video-on-Demand Content License Agreement includes an unlimited or all-you-can-eat license. It only identifies the parties involved and the effective date of the agreement. Therefore, based on the information given, I cannot confirm if the contract includes such a license. Further details from the agreement would be needed to determine the nature of the licensing terms.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What are the audit rights under this contract?",
        "response":"The retrieved chunk does not provide any information regarding the audit rights under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. Therefore, I cannot answer your question based on the provided text. If you have access to additional sections of the agreement, I would be happy to help analyze those for audit rights or any other specific clauses.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there uncapped liability under this contract?",
        "response":"The retrieved chunk does not provide specific information regarding liability, including whether there is uncapped liability under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. To determine if there is uncapped liability, one would need to review the full text of the agreement, particularly any clauses related to liability, indemnification, or limitations of liability. The provided excerpt does not contain these details.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a cap on liability under this contract?",
        "response":"The provided clause does not contain any information regarding a cap on liability under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. Therefore, based on the retrieved chunk, I cannot confirm whether there is a cap on liability as it is not addressed in the text.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What is the renewal term for this contract?",
        "response":"The clause does not provide information regarding a renewal term for the contract between ConvergTV, Inc. and Fulucai Productions Ltd. It states that the license term is \"Perpetual, unlimited runs\" and also mentions \"Other: 2 years,\" but it does not specify any conditions or terms for renewal after this period. Therefore, based on the provided clause, there is no clear renewal term stated.",
        "retrieved_contexts":[
            ": x Free: Terrestrial, Cable, Satellite x Pay: Terrestrial, Cable, Satellite x Direct Satellite IP Distribution Systems Licensed Territory x Worldwide \u00a8 Other: _______________________________________________ License Term Perpetual, unlimited runs x Other: 2 years Commencing: November 15, 2012 Run Dates Within ConvergTV determined parameters"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd. It primarily discusses the binding nature of the agreement and the parties involved, stating that it is \"subject to the restrictions against assignment\" and will \"inure to the benefit of the Parties.\" However, there is no mention of the governing law or jurisdiction applicable to the contract. Therefore, based on the retrieved chunk, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does this contract include an exclusivity agreement?",
        "response":"The retrieved chunk does not provide any information regarding an exclusivity agreement between ConvergTV, Inc. and Fulucai Productions Ltd. It states that \"there are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.\" This implies that if there were any exclusivity terms, they would need to be explicitly stated in the contract. Since the clause does not mention exclusivity, we cannot conclude that the contract includes an exclusivity agreement.",
        "retrieved_contexts":[
            ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not contain any information regarding revenue or profit-sharing arrangements in the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd. It only mentions \"any information contained in this Agreement\" without specifying any terms related to revenue or profit-sharing. Therefore, based on the clause, there is no direct answer regarding such arrangements.",
        "retrieved_contexts":[
            ": (i) any information contained in this Agreement"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does the licensee's affiliates have any licensing rights under this contract?",
        "response":"The retrieved chunk does not provide any information regarding the licensing rights of the licensee's affiliates under the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd. It specifically discusses the Producer's right to dispute revenue share payouts and mentions program exclusivity, but does not address the rights of affiliates. Therefore, I cannot provide a direct answer to your question based on the provided clause.",
        "retrieved_contexts":[
            ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What are the audit rights under this contract?",
        "response":"Under the Content Distribution and License Agreement, each Party has the right to audit the other Party's compliance with the Agreement. This includes auditing the other Party's representations and warranties. Importantly, the audits are to be conducted at the expense of the Party initiating the audit, as stated in the clause: \"Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement.\" \n\nThere are no additional conditions or restrictions mentioned in the provided clause regarding the audit rights.",
        "retrieved_contexts":[
            "18. Audit. Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement, including but not limited to, auditing the other Party's representations and warranties.   19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall be deemed to be one and the same instrument"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not provide an expiration date for the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. It only states the \"Effective Date\" as February 10, 2014. There are no terms mentioned regarding the duration or expiration of the contract. Therefore, based on the provided information, I cannot determine the expiration date of the contract.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the renewal term for this contract?",
        "response":"The retrieved chunk does not provide information regarding the renewal term for the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. It only includes the introductory details of the agreement, such as the parties involved and the effective date. Therefore, I cannot provide an answer regarding the renewal term as it is not stated in the provided text.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the notice period required to terminate the renewal?",
        "response":"The retrieved chunk does not provide any information regarding the notice period required to terminate the renewal of the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. Therefore, I cannot answer your question based on the provided text.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the governing law for this contract?",
        "response":"The retrieved chunk does not specify the governing law for the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. Therefore, I cannot provide an answer regarding the governing law based on the information given.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not explicitly mention an exclusivity agreement between PSiTech Corporation and Empirical Ventures, Inc. It only outlines the parties involved and the date of the agreement. There are no terms, conditions, or restrictions related to exclusivity included in the retrieved chunk. Therefore, based on the information available, it cannot be determined if the contract includes an exclusivity agreement.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The retrieved chunk does not provide any information regarding the consequences of a change of control of one of the parties in the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. Therefore, I cannot answer your question based on the provided text. If you have access to additional sections of the agreement, particularly those addressing change of control or termination, I would be happy to help analyze those.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. The clause states that \"Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect.\" This indicates that assignments, delegations, or transfers that do not comply with the specified conditions are invalid. However, it also specifies that the Licensor may freely assign or transfer its rights and obligations without the Licensee's consent, which suggests that while there is a restriction on the Licensee's ability to assign, the Licensor has more flexibility.",
        "retrieved_contexts":[
            ". Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect. Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not mention any revenue or profit-sharing arrangements between PSiTech Corporation and Empirical Ventures, Inc. It only outlines the parties involved in the Content License Agreement and their respective addresses. There are no terms, conditions, or restrictions related to revenue or profit-sharing included in the retrieved chunk. Therefore, based on the information available, the contract does not include any such arrangements.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What licenses are granted under this contract?",
        "response":"The retrieved chunk does not provide specific details regarding the licenses granted under the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. It only identifies the parties involved and the date of the agreement. To determine the licenses granted, one would need to refer to additional sections of the agreement that outline the specific terms, conditions, and scope of the licenses.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Are the licenses granted under this contract non-transferable?",
        "response":"The retrieved chunk does not provide specific information regarding whether the licenses granted under the Content License Agreement are non-transferable. Therefore, I cannot confirm the transferability of the licenses based on the provided text. If there are additional clauses in the full agreement that address this issue, they would need to be reviewed to provide a definitive answer.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What are the audit rights under this contract?",
        "response":"The provided chunk does not contain any information regarding the audit rights under the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. Therefore, I cannot provide an answer to your question based on the available text. If you have access to additional sections of the agreement, please provide them for further analysis.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there uncapped liability under this contract?",
        "response":"The provided clause does not contain any information regarding liability, including whether there is uncapped liability under the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. To determine if there is uncapped liability, one would need to review additional sections of the Agreement that specifically address liability terms, limitations, or caps. Therefore, based on the retrieved chunk, I cannot provide a direct answer regarding uncapped liability.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there a cap on liability under this contract?",
        "response":"Yes, there is a cap on liability under the contract. According to Section 9.2, \"EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.\" \n\nHowever, it's important to note that this cap does not apply to the Licensee's indemnification obligations under Section 8.2, or in cases of the Licensee's gross negligence or willful misconduct, as stated in Section 9.3.",
        "retrieved_contexts":[
            "9.2 Cap on Monetary Damages. EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.   9.3 Exceptions. The provisions of Section 9.1 and Section 9.2 will not apply to limit the Licensee's indemnification obligations under Section 8.2, or in the case of Licensee's gross negligence or wilful misconduct.   10. Confidentiality"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not provide an expiration date for the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. It only states the effective date of the agreement as December 21, 2015. Therefore, without additional information from the full agreement, I cannot determine the expiration date.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. Therefore, I cannot provide an answer regarding the governing law based on the information given in the clause.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"The provided clause indicates that any contract that \"grants any rights of first refusal or rights of first negotiation\" is relevant to your question. However, it does not specify whether the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. actually includes such rights. \n\nTo determine if the specific contract includes a right of first refusal, right of first offer, or right of first negotiation, you would need to review the actual terms of that agreement. The clause only states the conditions under which such rights may exist but does not confirm their presence in the mentioned contract.",
        "retrieved_contexts":[
            ";   (iii)            each Contract that (A) grants any exclusive rights to any Third Party, including any exclusive license or supply or distribution agreement or other exclusive rights or which, pursuant to its terms, could have such effect after the Closing solely as a result of the consummation of the transactions contemplated hereby, (B) grants any rights of first refusal or rights of first negotiation with respect to any product, service or Company Owned IP"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"The provided clause does not contain any information regarding an anti-assignment clause in the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. It only includes the introductory details of the agreement, such as the parties involved and the effective date. Therefore, based on the retrieved chunk, there is no indication of an anti-assignment clause present in this contract.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not mention any revenue or profit-sharing arrangements between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. It only identifies the parties involved in the Content License Agreement and their addresses. There are no terms, conditions, or restrictions related to revenue or profit-sharing included in this excerpt. Therefore, based on the information given, it cannot be concluded that such arrangements are part of this contract.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What are the audit rights under this contract?",
        "response":"The provided clause does not contain any information regarding audit rights under the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. Therefore, I cannot provide details about audit rights as they are not specified in the retrieved chunk.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there uncapped liability under this contract?",
        "response":"The provided clause does not contain any information regarding liability, including whether there is uncapped liability under the Content License Agreement. Therefore, based on the retrieved chunk, I cannot determine if there is uncapped liability in this contract. If you have additional sections of the agreement that address liability, please provide them for further analysis.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there a cap on liability under this contract?",
        "response":"The provided clause does not contain any information regarding a cap on liability under the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. Therefore, based on the retrieved chunk, there is no mention of any limitations or caps on liability.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What is the expiration date of this contract?",
        "response":"The contract has a term of three (3) years from the effective date stated in the agreement. However, it can be terminated earlier by PrimeCall with thirty (30) days' written notice. Since the specific effective date is not provided in the retrieved chunk, the exact expiration date cannot be determined without that information. Therefore, the expiration date of the contract will be three years from the effective date mentioned in the agreement.",
        "retrieved_contexts":[
            "Section 1.01. Term. The term of this Agreement shall be effective as of the date first stated above and shall continue for a term of three (3) years, unless terminated earlier in accordance with the provisions of this Agreement (the \"Term\"); provided, however, that PrimeCall may elect to terminate this Agreement, upon thirty (30) days' written notice, at any time from and after the time that collectively RSL Communications, Ltd"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. It focuses on the obligations of each party to execute necessary instruments and take actions related to the performance of the agreement. Therefore, there is no information regarding the governing law stated in the clause.",
        "retrieved_contexts":[
            ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The provided clause does not address what happens in the event of a change of control of one of the parties in the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. It focuses on the obligations of each party to execute and deliver instruments and take actions as reasonably required for the performance of the agreement. Therefore, there is no information regarding the consequences or procedures related to a change of control.",
        "retrieved_contexts":[
            ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"The provided clause does not mention an anti-assignment provision. It specifically addresses the relationship between the parties, stating that they are independent contractors and that neither party has the right to act on behalf of the other. However, it does not contain any terms or conditions regarding the assignment of rights or obligations under the contract. Therefore, based on the information in the clause, there is no indication of an anti-assignment clause in the contract.",
        "retrieved_contexts":[
            "Section 9.04  [Independent Contractors]. Independent Contractors. At all times the parties hereto shall be considered independent contractors and this Agreement shall not create any agency, partnership or employment relationship between the parties. Except as specifically set forth herein, neither party shall have the right to act for or on behalf of or in the name of the other party."
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What licenses are granted under this contract?",
        "response":"Under the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc., a limited license is granted to each party to use the other's proprietary marks. This license is specifically for the purpose of \"the sale, distribution, marketing and promotion of each party's calling cards by the other party.\" \n\nAdditionally, it is important to note that both parties must exercise this license in compliance with the \"quality and other standards established by the party owning such marks.\" This means that the use of the proprietary marks is not only limited to the specified activities but also subject to the quality standards set by the mark owner.",
        "retrieved_contexts":[
            "Section 2.03  [Limited License]. Limited License. Throughout the Term of this Agreement, the parties hereby agree to grant to each other a limited license to use each other's proprietary marks solely in connection with the sale, distribution, marketing and promotion of each party's calling cards by the other party. Both parties hereto shall exercise such license in compliance with the quality and other standards established by the party owning such marks"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; Is there a cap on liability under this contract?",
        "response":"The provided clause does not contain any information regarding a cap on liability under the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. It only mentions \"Limited Warranty\" without detailing any terms, conditions, or restrictions related to liability. Therefore, based on the clause, there is no direct answer to your question about a cap on liability.",
        "retrieved_contexts":[
            "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the renewal term for this contract?",
        "response":"The renewal term for the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. is twelve (12) months. The agreement states that it shall \"automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term.\" However, either party can prevent this renewal by providing written notice at least sixty (60) days prior to the end of the Initial Term.",
        "retrieved_contexts":[
            ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the notice period required to terminate the renewal?",
        "response":"The notice period required to terminate the renewal of the Co-Branding Agreement is at least sixty (60) days prior to the end of the Initial Term. This is explicitly stated in the clause: \"unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term.\"",
        "retrieved_contexts":[
            ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. It focuses on the obligations of the parties, their compliance with agreements, and the enforceability of the contract. Therefore, based on the information in the clause, there is no direct answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            "by such party of its obligations and duties hereunder, do not and will not violate any agreement to which such party is a party or by which it is bound, (c) when executed and delivered by such party, this Agreement will constitute the legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms and (d) such party will perform its obligations hereunder in compliance with applicable law and regulations."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are there any exceptions to competitive restrictions in this contract?",
        "response":"The retrieved chunk does not provide any specific information regarding exceptions to competitive restrictions in the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. The clause only mentions \"EXCLUSIVITY\" without detailing any terms, conditions, or exceptions related to competitive restrictions. Therefore, based on the provided information, I cannot confirm whether there are any exceptions to competitive restrictions in this contract.",
        "retrieved_contexts":[
            "5.       EXCLUSIVITY."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"The retrieved clause does not address any rights of first refusal, right of first offer, or right of first negotiation. It specifically states that \"the parties are independent contractors\" and emphasizes that the agreement does not create any partnership, agency, or joint venture. Therefore, based on the provided information, there is no indication that such rights are included in the contract.",
        "retrieved_contexts":[
            "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The retrieved clause defines \"Change in Control\" as a merger or consolidation of one party with another, or a sale of all or substantially all of the assets of one party to another entity. However, it does not specify what happens in the event of a change of control. Therefore, based on the provided clause, there is no information regarding the consequences or actions that would take place if a change of control occurs for either Women.com Networks, Inc. or eDiets.com, Inc.",
        "retrieved_contexts":[
            ". For purposes of this Agreement, \"Change in Control\" means a merger or consolidation of the party with, or any sale of all or substantially all of the assets of such party to, any other person, corporation or entity, unless as a result of such merger"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are there any price restrictions or controls specified in this contract?",
        "response":"The provided clause does not mention any price restrictions or controls related to the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. It specifically addresses the confidentiality of the terms and conditions of the Agreement, stating that they will be considered Confidential Information and cannot be disclosed without written consent from the other party. \n\nSince there is no reference to pricing or financial terms in the retrieved chunk, I cannot provide any information regarding price restrictions or controls.",
        "retrieved_contexts":[
            "11.8 The terms and conditions of this Agreement will be deemed to be the Confidential Information of each party and will not be disclosed without the written consent of the other party.\n\n12.      WARRANTY."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a minimum commitment required under this contract?",
        "response":"The retrieved clause does not provide any information regarding a minimum commitment required under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. It specifically addresses the relationship between the parties, stating that they are independent contractors and that the agreement does not create any partnership, agency, or joint venture. Therefore, based on the provided clause, there is no mention of any minimum commitment requirements.",
        "retrieved_contexts":[
            "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What licenses are granted under this contract?",
        "response":"The provided clause does not specify the licenses granted under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. It only addresses liability limitations, stating that \"EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT,\" neither party will be liable for certain types of damages. However, it does not detail what those license grants are. Therefore, based on the clause, I cannot provide information about the specific licenses granted under this contract.",
        "retrieved_contexts":[
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are the licenses granted under this contract non-transferable?",
        "response":"The retrieved chunk does not provide any information regarding whether the licenses granted under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. are non-transferable. It specifically addresses liability limitations, stating that \"EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT,\" neither party will be liable for certain types of damages. However, it does not clarify the transferability of the licenses. Therefore, based on the provided clause, I cannot determine if the licenses are non-transferable.",
        "retrieved_contexts":[
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there uncapped liability under this contract?",
        "response":"The provided clause titled \"LIMITATION OF LIABILITY\" does not include any specific details or terms regarding liability, including whether there is uncapped liability under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. Therefore, based on the information given in the clause, it cannot be determined if there is uncapped liability under this contract.",
        "retrieved_contexts":[
            "14.      LIMITATION OF LIABILITY"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a cap on liability under this contract?",
        "response":"The retrieved chunk does not provide specific details regarding the limitation of liability or whether there is a cap on liability under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. Therefore, I cannot confirm if there is a cap on liability based on the information provided. You may need to refer to the full text of the agreement for detailed terms related to liability.",
        "retrieved_contexts":[
            "14.      LIMITATION OF LIABILITY"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a covenant not to sue included in this contract?",
        "response":"The provided clause does not explicitly mention a covenant not to sue. Instead, it focuses on the rights of each party to participate in the defense of indemnifiable claims and the requirement for prior written consent before settling any such claims. Specifically, it states that \"Each party, as Indemnitee, may participate, at its own cost, in the defense of any indemnifiable claim\" and that \"Each party agrees not to settle any indemnifiable claim without the prior written consent of the other party.\" \n\nHowever, there is no indication in this clause about a prohibition on suing or a covenant not to sue. Therefore, based on the information provided, there is no covenant not to sue included in this contract.",
        "retrieved_contexts":[
            ". Each party, as Indemnitee, may participate, at its own cost, in the defense of any indemnifiable claim with counsel of its own choosing. Each party agrees not to settle any indemnifiable claim without the prior written consent of the other party, which consent shall not be unreasonably withheld or delayed."
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What is the expiration date of this contract?",
        "response":"The provided clause does not specify an expiration date for the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, based on the information available, I cannot provide an answer regarding the expiration date of this contract.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What is the governing law for this contract?",
        "response":"The retrieved chunk does not provide information regarding the governing law for the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, I cannot answer your question based on the provided clause.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a most favored nation clause in this contract?",
        "response":"The provided clause indicates that there is a restriction related to \"most favored nation\" pricing. It states that a contract cannot grant a \"most favored nation\" or most favored customer pricing to any person, nor can it provide exclusive rights that materially limit the company's ability to engage in business. \n\nHowever, the clause does not explicitly confirm whether the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series contains a most favored nation clause. It only outlines the conditions under which such a clause would be restricted. Therefore, based on the information provided, I cannot determine if there is a most favored nation clause in that specific contract.",
        "retrieved_contexts":[
            ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and\/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not explicitly mention an exclusivity agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, based on the information available in the clause, it cannot be determined whether an exclusivity agreement is included in the contract.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not specify any details regarding revenue or profit-sharing arrangements between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, based on the information available in the clause, it cannot be determined whether such arrangements exist.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a minimum commitment required under this contract?",
        "response":"The retrieved chunk does not provide specific details regarding a minimum commitment required under the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, I cannot confirm whether there is a minimum commitment stated in the contract. If you have access to additional sections of the agreement, please provide them for a more thorough analysis.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include any volume restrictions?",
        "response":"The provided clause does not specify any volume restrictions related to the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, based on the information available in the clause, there are no stated volume restrictions in this contract.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract provide for joint intellectual property ownership?",
        "response":"The retrieved chunk does not provide specific information regarding joint intellectual property ownership in the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, I cannot confirm whether the contract includes provisions for joint intellectual property ownership based on the provided text.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What licenses are granted under this contract?",
        "response":"The retrieved chunk does not provide specific details regarding the licenses granted under the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, I cannot provide an answer regarding the licenses as the relevant information is not included in the provided text.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What are the audit rights under this contract?",
        "response":"The provided retrieved chunk does not contain specific information regarding the audit rights under the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, I cannot provide details about the audit rights as they are not mentioned in the clause. If you have access to additional sections of the contract that may contain this information, please provide them for further analysis.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a covenant not to sue included in this contract?",
        "response":"The retrieved chunk does not provide any specific information regarding a covenant not to sue in the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. Therefore, based on the provided text, I cannot confirm whether such a covenant is included in the contract.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the expiration date of this contract?",
        "response":"The expiration date of the Co-Branding and Endorsement Licensing Agreement is July 22, 2019. This is stated in the clause, which specifies that \"the Agreement shall expire and terminate automatically without further notice on July 22, 2019\" if it is renewed for the First Additional Term commencing on July 23, 2016.",
        "retrieved_contexts":[
            ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the renewal term for this contract?",
        "response":"The renewal term for the contract is referred to as the \"First Additional Term,\" which commences on July 23, 2016, and expires automatically on July 22, 2019, without further notice. This is contingent upon the agreement being renewed for the First Additional Term, as stated in the clause: \"If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019.\"",
        "retrieved_contexts":[
            ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc. It only addresses the assignment or transfer of rights and obligations under the agreement, stating that \"Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations... without the prior written consent of the other party.\" \n\nTo find the governing law, you would need to refer to another section of the contract that explicitly states the governing law or jurisdiction.",
        "retrieved_contexts":[
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Are there any exceptions to competitive restrictions in this contract?",
        "response":"The provided clause does not address any exceptions to competitive restrictions in the Co-Branding and Endorsement Licensing Agreement. It specifically outlines the Guaranteed Minimum Royalty payments for the initial term, detailing the amounts and timing of those payments for each contract year. However, it does not mention any competitive restrictions or exceptions related to them. Therefore, based on the information in the clause, there are no details regarding exceptions to competitive restrictions.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a non-compete clause in this contract?",
        "response":"Yes, there is a non-compete clause in the contract, but it includes a specific condition. The clause states that the \"Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm.\" This means that while there is a non-competition obligation, it is not enforceable if MusclePharm materially breaches the agreement.",
        "retrieved_contexts":[
            ". Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not address whether the Co-Branding and Endorsement Licensing Agreement includes an exclusivity agreement. It specifically pertains to the restrictions on making news releases or public announcements regarding the agreement without prior written consent from the other party. There is no mention of exclusivity or related terms in the clause. Therefore, based on the information given, I cannot confirm if an exclusivity agreement is included in the contract.",
        "retrieved_contexts":[
            ":   Neither party may, without the other party's prior written consent, make any news release or public announcement of the existence or value of this Agreement or its terms and conditions, or in any other manner advertise or publish its value, or its terms and conditions and neither party shall issue any press release or other public announcement which includes the name of the other party without such party's prior written consent, such consent not to be unreasonably withheld or delayed"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"The provided clause does not mention any right of first refusal, right of first offer, or right of first negotiation. It solely outlines the guaranteed minimum royalty payments during the initial term of the contract, specifying the amounts and payment dates for each contract year. Therefore, based on the information in the clause, there is no indication that such rights are included in the agreement.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The provided clause does not address what happens in the event of a change of control of one of the parties in the contract. It specifically states that \"Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.\" This means that any assignment or transfer of rights and obligations requires consent, and any attempt to do so without consent would be considered void. However, it does not mention how a change of control would be treated under the agreement. Therefore, based on the clause provided, there is no direct answer regarding the implications of a change of control.",
        "retrieved_contexts":[
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. The clause states that \"Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.\" This means that any assignment or transfer of rights and obligations requires the written consent of the other party. Additionally, it specifies that \"Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void.\" This clearly establishes the restriction on assignment or transfer without consent.",
        "retrieved_contexts":[
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not mention any revenue or profit-sharing arrangements. It specifically outlines the \"Guaranteed Minimum Royalty during the initial Term,\" detailing the minimum royalty amounts for each contract year and the timing of payments. The clause states:\n\n- For Contract Year One, the minimum royalty is $1,500,000, with payments of $500,000 due on specified dates.\n- For Contract Year Two, the minimum royalty is $2,000,000, with payments of $666,666.66 due on specified dates.\n- For Contract Year Three, the minimum royalty is $2,500,000, with payments of $833,333.33 due on specified dates.\n\nHowever, there is no indication of any revenue or profit-sharing arrangements in this clause. Therefore, based on the information provided, the contract does not include such arrangements.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a minimum commitment required under this contract?",
        "response":"Yes, there is a minimum commitment required under the contract. The clause states that the Lender is entitled to receive a \"guaranteed minimum royalty for each Contract Year including the Additional Term, if any.\" This indicates that there is a specified minimum payment that must be made annually, as outlined in Exhibit \"C\" attached to the agreement.",
        "retrieved_contexts":[
            ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any volume restrictions?",
        "response":"The provided clause does not mention any volume restrictions related to the Co-Branding and Endorsement Licensing Agreement. It specifically outlines the Guaranteed Minimum Royalty during the initial term, detailing the minimum royalty amounts and the timing of payments for each contract year. However, it does not include any terms, conditions, or restrictions regarding volume. Therefore, based on the information in the clause, there are no volume restrictions stated in the contract.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; How is intellectual property ownership assigned in this contract?",
        "response":"The provided clause does not directly address how intellectual property ownership is assigned in the Co-Branding and Endorsement Licensing Agreement. Instead, it states that \"nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm\" after the termination of the Agreement. This implies that MusclePharm retains certain rights to use its intellectual property even after the Agreement ends, but it does not clarify the overall assignment of ownership of intellectual property within the contract. Therefore, the clause does not provide a complete answer to your question regarding the assignment of intellectual property ownership.",
        "retrieved_contexts":[
            ", nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What licenses are granted under this contract?",
        "response":"The provided clause does not specify the licenses granted under the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc. Instead, it outlines certain representations and warranties made by the parties involved, such as their authority to enter into the agreement and the requirement that the Licensed Products and related materials must not contain any obscene, libelous, slanderous, or defamatory content.\n\nTo determine the specific licenses granted under this contract, additional clauses or sections of the agreement would need to be reviewed, as this excerpt does not provide that information.",
        "retrieved_contexts":[
            ":   (i) It has the full right, power and authority to enter into this Agreement and to perform its obligations hereunder; (ii) it has acquired all rights necessary to perform this Agreement and exploit the Licensed Products as contemplated herein; (iii) the Licensed Products, any element thereof, or any advertising, promotional or publicity materials supplied by Licensee or third parties hereunder will not contain any language or material which is obscene, libelous, slanderous or defamatory"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Are there any services to be provided after the termination of this contract?",
        "response":"According to the clause provided, \"Upon expiration or termination of the Agreement... Endorser shall have no further obligation to render any services whatsoever.\" This clearly states that after the termination of the contract, there are no services that the Endorser is required to provide. Therefore, there will be no services provided after the termination of the Co-Branding and Endorsement Licensing Agreement.",
        "retrieved_contexts":[
            ": Upon expiration or termination of the Agreement for pursuant to Section 9 herein, Endorser shall have no further obligation to render any services whatsoever"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What are the audit rights under this contract?",
        "response":"The audit rights under the Co-Branding and Endorsement Licensing Agreement state that the AS Parties have the right to inspect MusclePharm's books and records related to the Licensed Products. This inspection can occur upon providing at least five (5) days written notice and is limited to no more than once each Contract Year during the Term of the agreement. The inspection can take place at the locations where MusclePharm normally retains these records.",
        "retrieved_contexts":[
            ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a cap on liability under this contract?",
        "response":"Yes, there is a cap on liability under the Co-Branding and Endorsement Licensing Agreement. The clause states that \"in no event shall the AS Parties' indemnification obligations to MusclePharm hereunder exceed the after-tax value of the Cash Consideration received by Lender under this Agreement.\" This indicates that the indemnification obligations are limited to a specific amount, which is the after-tax value of the cash consideration received.",
        "retrieved_contexts":[
            ". In no event shall the AS Parties' indemnification obligations to MusclePharm hereunder exceed the after-tax value of the Cash Consideration received by Lender under this Agreement.   (b) By MusclePharm"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What are the insurance requirements under this contract?",
        "response":"Under the Co-Branding and Endorsement Licensing Agreement, MusclePharm is required to obtain and maintain a commercial general liability insurance policy. This policy must be from a qualified insurance company licensed to operate in California and New York. The insurance coverage must include:\n\n1. **Contractual Liability** - This applies to the terms and conditions of the agreement.\n2. **Product Liability**\n3. **Personal Injury Liability**\n4. **Advertiser's Liability**\n\nAdditionally, MusclePharm must maintain this insurance throughout the term of the agreement and for a period of not less than four years thereafter, at its own cost and expense.",
        "retrieved_contexts":[
            ":   MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a covenant not to sue included in this contract?",
        "response":"The retrieved chunk does not provide specific information regarding a covenant not to sue in the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc. Therefore, I cannot confirm whether such a covenant is included in the contract based on the provided text.",
        "retrieved_contexts":[
            ". Representations, Warranties and Covenants"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the expiration date of this contract?",
        "response":"The provided clause does not specify an expiration date for the Co-Branding Agreement. It only mentions that the terms of the agreement are in effect \"during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof.\" To determine the actual expiration date, one would need to refer to the specific start date of the agreement, which is not included in the retrieved chunk.",
        "retrieved_contexts":[
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the renewal term for this contract?",
        "response":"The renewal term for the Co-Branding Agreement is an additional period of three (3) years. This renewal occurs automatically following the Initial Term, unless a party provides written notice of termination at least sixty (60) days prior to the expiration of the Initial Term or the Agreement. This is referred to as the \"Extended Term\" in the clause.",
        "retrieved_contexts":[
            ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the notice period required to terminate the renewal?",
        "response":"The notice period required to terminate the renewal of the Co-Branding Agreement is at least sixty (60) days. This is specified in the clause, which states that a party must provide \"written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement.\"",
        "retrieved_contexts":[
            ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Co-Branding Agreement between the parties mentioned. It only addresses liability limitations, stating that \"IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES... FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES.\" Therefore, based on the retrieved chunk, there is no information regarding the governing law of the contract.",
        "retrieved_contexts":[
            "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a most favored nation clause in this contract?",
        "response":"The provided clause does not contain any information regarding a most favored nation clause in the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited. The clause primarily discusses agreements related to entities operating in multiple international markets, including the PRC, but does not explicitly mention a most favored nation clause or any related terms. Therefore, based on the retrieved chunk, there is no indication of a most favored nation clause in the contract.",
        "retrieved_contexts":[
            "., with HGC), or (b) to any agreement now existing or hereafter entered into with an entity that operates in multiple international markets, which may include the PRC, so long as such agreement applies to multiple territories, which may include the PRC in addition to other territories, and does not, directly or indirectly"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Are there any exceptions to competitive restrictions in this contract?",
        "response":"Yes, there are exceptions to the competitive restrictions in the contract. According to Section 8.3, the Non-Competition Period can terminate prior to the End Date. This means that once the Non-Competition Period is terminated, \"no party shall be obligated to comply with the restrictions set out in Section 8.1.\" Therefore, if the Non-Competition Period ends, the parties are no longer bound by the competitive restrictions specified in the contract.",
        "retrieved_contexts":[
            "8.2.2 with respect to the provisions of Section 8.1.2, during any period following the expiration of the Enterprise Non-Competition Period.\n\n8.3 Termination of Non-Competition Period. Notwithstanding any portion of the foregoing to the contrary, the Non-Competition Period shall terminate prior to the End Date, and for the avoidance of doubt, no party shall be obligated to comply with the restrictions set out in Section 8.1 after the termination of the Non-Competition Period:"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a non-compete clause in this contract?",
        "response":"Yes, there is a non-compete clause in the Co-Branding Agreement. Specifically, Section 8.1 outlines restrictions related to non-competition, and Section 8.2.2 refers to provisions concerning the Enterprise Non-Competition Period. Additionally, Section 8.3 states that the Non-Competition Period can terminate before the End Date, indicating that parties are not obligated to comply with the restrictions after the Non-Competition Period ends. Therefore, while there is a non-compete clause, its enforceability is subject to the specified time frame and conditions outlined in these sections.",
        "retrieved_contexts":[
            "8.2.2 with respect to the provisions of Section 8.1.2, during any period following the expiration of the Enterprise Non-Competition Period.\n\n8.3 Termination of Non-Competition Period. Notwithstanding any portion of the foregoing to the contrary, the Non-Competition Period shall terminate prior to the End Date, and for the avoidance of doubt, no party shall be obligated to comply with the restrictions set out in Section 8.1 after the termination of the Non-Competition Period:"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The provided clause does not address the scenario of a change of control of one of the parties in the Co-Branding Agreement. It only specifies that any party has the right to terminate the Agreement during the Term by giving notice to another party or to any party that is not an Affiliate of the terminating party. Therefore, there is no information regarding the consequences or actions to be taken in the event of a change of control.",
        "retrieved_contexts":[
            ". Any party to this Agreement shall have the right to terminate this Agreement during the Term by giving notice to another party to this Agreement or to any party that is not an Affiliate of the terminating party (collectively, \"Defaulter\")"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the Co-Branding Agreement. According to the clause 14.4, \"This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement.\" Additionally, it states that \"any attempt at assignment in violation of this section shall be null and void.\" This means that any party cannot assign their rights or obligations under the agreement without obtaining written consent from the other parties involved.",
        "retrieved_contexts":[
            "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not explicitly mention any revenue or profit-sharing arrangements. It only refers to the \"determination of the amounts of Gross Revenue under this Agreement,\" but does not detail how that revenue is shared or distributed among the parties involved. Therefore, based on the information in the clause, there is no clear indication of revenue or profit-sharing arrangements in the Co-Branding Agreement.",
        "retrieved_contexts":[
            ", the determination of the amounts of Gross Revenue under this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; How is intellectual property ownership assigned in this contract?",
        "response":"The clause specifies that if any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under the Agreement, the ownership of such intellectual property rights will be determined according to the terms outlined in the contract. However, the specific details regarding how the ownership is assigned are not provided in the retrieved chunk. Therefore, to fully understand the assignment of intellectual property ownership in the Co-Branding Agreement, one would need to refer to the complete contract for the detailed provisions regarding ownership.",
        "retrieved_contexts":[
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does this contract provide for joint intellectual property ownership?",
        "response":"Yes, the contract provides for joint intellectual property ownership. According to clause 4.2.3.2, if any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, those rights shall be owned jointly. This indicates that any jointly developed intellectual property will not be owned by one party alone but rather shared among the involved parties.",
        "retrieved_contexts":[
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What licenses are granted under this contract?",
        "response":"The retrieved chunk does not provide specific details about the licenses granted under the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited. It only mentions \"4.1 Licenses\" without elaborating on the terms, conditions, or specifics of the licenses. Therefore, I cannot provide an answer regarding the licenses granted under this contract based on the provided information.",
        "retrieved_contexts":[
            "4. PROPRIETARY RIGHTS & LICENSE GRANTS\n\n4.1 Licenses."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does the licensor's affiliates have any licensing rights under this contract?",
        "response":"The retrieved chunk does not provide specific information regarding whether the licensor's affiliates have any licensing rights under the Co-Branding Agreement. It only states that \"upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate,\" and refers to Section 4.2.3.2.3 and Section 6 for further details. \n\nTo determine the licensing rights of the licensor's affiliates, you would need to review those specific sections mentioned in the clause, as they may contain relevant information regarding the rights of affiliates.",
        "retrieved_contexts":[
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does the licensee's affiliates have any licensing rights under this contract?",
        "response":"The provided clause does not explicitly mention whether the licensee's affiliates have any licensing rights under the Co-Branding Agreement. It states that \"upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate,\" but it does not clarify the rights of affiliates specifically. Therefore, based on the information in the clause, we cannot determine if the licensee's affiliates have any licensing rights under this contract.",
        "retrieved_contexts":[
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Are there any services to be provided after the termination of this contract?",
        "response":"The clause provided does not specify any services to be provided after the termination of the contract. It states that upon termination or expiration of the Agreement, certain actions will occur, but it does not detail any ongoing services or obligations that the parties must fulfill post-termination. Therefore, based on the information in the clause, there are no services explicitly mentioned to be provided after the termination of the contract.",
        "retrieved_contexts":[
            "Source: TOM ONLINE INC, 20-F, 5\/1\/2006\n\n\n\n\n\n6.3 Duties Upon Termination. Subject to Section 6.5 and to the extent required for the Parties to give effect to Section 6.4, upon termination or expiration of this Agreement, the following shall occur:"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What are the audit rights under this contract?",
        "response":"The audit rights under the Co-Branding Agreement are outlined in Section 5.4, which states that \"The Parties (including Online BVI on behalf of the Online Group) agree to maintain records (i) of all information reasonably necessary to verify all calculations to be made under Section 8.3.\" \n\nThis means that the parties involved in the agreement are required to keep records that are necessary for verifying calculations related to Section 8.3. However, the clause does not specify the exact nature of the audit process or any additional rights or procedures related to audits beyond the maintenance of these records.",
        "retrieved_contexts":[
            "5.4 Audit Rights. The Parties (including Online BVI on behalf of the Online Group) agree to maintain records (i) of all information reasonably necessary to verify all calculations to be made under Section 8.3"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there uncapped liability under this contract?",
        "response":"The retrieved chunk does not provide specific information regarding the limitation of liability in the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited. Therefore, I cannot determine whether there is uncapped liability under this contract based on the provided clause. \n\nFor a definitive answer, the full text of the limitation of liability clause would need to be reviewed to identify any caps or restrictions on liability.",
        "retrieved_contexts":[
            "12.2 Limitation of Liability."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a cap on liability under this contract?",
        "response":"The provided clause \"12.2 Limitation of Liability\" does not contain any specific details regarding a cap on liability. Therefore, based on the information available in this clause, it is unclear whether there is a cap on liability under the Co-Branding Agreement between the parties mentioned. If you need more information, it may be necessary to review the entire contract or additional clauses related to liability.",
        "retrieved_contexts":[
            "12.2 Limitation of Liability."
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not provide any information regarding the expiration date of the Development Agreement between Howmedica Osteonics Corp. and Conformis, Inc. It only includes the execution details, such as the parties involved, their signatures, and the dates of execution (September 26, 2019, and September 30, 2019). Therefore, I cannot determine the expiration date of the contract based on the provided information.",
        "retrieved_contexts":[
            "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: \/s\/ Spencer Stiles By: \/s\/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11\/1\/2019"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation. Therefore, I cannot provide an answer regarding the governing law based on the information given in the clause.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Are there any exceptions to competitive restrictions in this contract?",
        "response":"Yes, there is an exception to the competitive restrictions in the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. The clause states that Conformis, including any entity involved in a Change of Control of Conformis (referred to as an \"Acquirer\"), is permitted to develop Patient-Specific Instrumentation for any Off-The-Shelf Implants of Conformis, an Acquirer, or any of their Affiliates. This indicates that despite the competitive restrictions, Conformis and its Acquirers have the right to engage in this specific development activity.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not explicitly mention an exclusivity agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation. It states that Conformis, including any entity involved in a Change of Control of Conformis (referred to as an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-Shelf Implants of Conformis, an Acquirer, or any of their Affiliates. \n\nThis indicates that Conformis and its Acquirers have the right to develop certain products, but it does not confirm whether there are exclusive rights granted to either party regarding the development or distribution of Patient-Specific Instrumentation. Therefore, based on the clause provided, there is no clear indication of an exclusivity agreement.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"The provided clause does not mention any specific rights such as a right of first refusal, right of first offer, or right of first negotiation in relation to the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. It lists various types of agreements, including stockholders agreements, joint venture agreements, and contracts with governmental entities, but does not explicitly state any terms related to the rights you inquired about. Therefore, based on the clause, there is no indication that such rights are included in the contract.",
        "retrieved_contexts":[
            "(xii) any stockholders agreements, voting agreements, registrations rights agreements, co-sale agreements and any other similar Contracts between the Company and any holder of Company capital stock\u037e \n\n\n(xiii) the Joint Venture Agreements for the Material Clinic Joint Ventures\u037e \n\n\n(xiv) any Contract between the Company or any of its Subsidiaries and any Governmental Entity and that is material to the Company and its Subsidiaries, taken as a whole\u037e"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract provide for joint intellectual property ownership?",
        "response":"The clause provided does not indicate that there is joint intellectual property ownership between Stryker and Conformis. Instead, it states that \"Conformis owns all right, title and interest, including all Intellectual Property rights, in and to Conformis Background IP and Conformis' Confidential Information.\" Furthermore, it specifies that \"Stryker shall acquire no right, title\" to these intellectual property rights under the agreement. Therefore, the contract does not provide for joint intellectual property ownership; rather, it affirms that Conformis retains sole ownership of its intellectual property.",
        "retrieved_contexts":[
            ".   (b) Stryker acknowledges and agrees that, as between the Parties, Conformis owns all right, title and interest, including all   Intellectual Property rights, in and to Conformis Background IP and Conformis' Confidential Information, including any Conformis   Confidential Information underlying the Joint IP, and that, under this Agreement, Stryker shall acquire no right, title"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What licenses are granted under this contract?",
        "response":"The provided clause does not specify any licenses granted under the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation. Instead, it mentions that Conformis, including any entity involved in a Change of Control (referred to as an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-Shelf Implants of Conformis, an Acquirer, or any of their Affiliates. \n\nHowever, it does not detail the specific licenses or rights granted to either party under the contract. Therefore, based on the retrieved chunk, there is no direct answer regarding the licenses granted.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does the licensee's affiliates have any licensing rights under this contract?",
        "response":"The clause does not explicitly state whether the licensee's affiliates have any licensing rights under the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. It mentions that Conformis and any entity involved in a Change of Control of Conformis (referred to as \"Acquirer\") may develop Patient-Specific Instrumentation for Off-The-Shelf Implants of Conformis, an Acquirer, or any of their Affiliates. However, it does not clarify the licensing rights of the licensee's affiliates specifically. Therefore, based on the provided clause, it cannot be determined if the licensee's affiliates have any licensing rights under this contract.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Is there uncapped liability under this contract?",
        "response":"The provided clause does not directly address the issue of uncapped liability under the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. It specifies that \"Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.\" This indicates that there are specific limitations on liability related to breaches of Section 3.2, but it does not provide details about whether liability is capped or uncapped in general terms.\n\nTo determine if there is uncapped liability, one would need to refer to Section 10.1(i) of the Distribution Agreement, as that section is referenced as containing the terms of liability. The clause itself does not provide enough information to conclude whether liability is capped or uncapped.",
        "retrieved_contexts":[
            ". Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.   (b) Indemnification by Stryker. Stryker shall indemnify and hold harmless Conformis, its directors, officers, employees, Agents   and   20   Source: CONFORMIS INC, 10-Q, 11\/1\/2019"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Is there a cap on liability under this contract?",
        "response":"The provided clause does not address the issue of liability or whether there is a cap on liability under the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. It specifically discusses the rights of Conformis and any Acquirer regarding the development of Patient-Specific Instrumentation for Off-The-Shelf Implants, but does not mention any terms related to liability or limitations thereof. Therefore, based on the information in the clause, I cannot provide an answer regarding a cap on liability.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What is the expiration date of this contract?",
        "response":"The provided retrieved chunk does not contain any information regarding the expiration date of the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It only includes a statement about the execution of the agreement and the parties involved. Therefore, I cannot provide an answer regarding the expiration date of the contract based on the information given.",
        "retrieved_contexts":[
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Therefore, based on the information in the clause, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ".3, then (a) ETON shall have the right to, and Aucta shall hereby grant ETON a license to, Market or otherwise dispose of any existing inventory of any Products then in ETON's possession subject to paying all Royalties and other amounts due hereunder for such sales"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a non-compete clause in this contract?",
        "response":"The provided clause does not explicitly mention a non-compete clause in the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Instead, it refers to \"any Contract of the Company\" and other agreements that may limit the ability of the Company or its Subsidiaries to compete. \n\nSpecifically, it states that there are no agreements, other than the Joint Venture Agreements, that \"limits the ability of the Company, any of its Subsidiaries or a Clinic Joint Venture to compete in any line of business or with any Person or in any geographic area or during any period of time.\" This suggests that the contract does not impose any material restrictions on competition relevant to the Company and its Subsidiaries.\n\nTherefore, based on the clause, there does not appear to be a non-compete clause in the contract you mentioned.",
        "retrieved_contexts":[
            "(iv) other than the Joint Venture Agreements, any Contract of the Company, any of its Subsidiaries or, to the knowledge of the Company, the Clinic Joint Ventures, that limits the ability of the Company, any of its Subsidiaries or a Clinic Joint Venture to compete in any line of business or with any Person or in any geographic area or during any period of time, in each case in any respect material to the Company, its Subsidiaries and the Clinic Joint Ventures, taken as a whole. \n\n\n15"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include an exclusivity agreement?",
        "response":"Yes, the contract includes an exclusivity agreement. The title of the document is \"EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT,\" which indicates that it involves exclusive rights related to licensing and product development. The term \"exclusive\" suggests that the agreement grants one party certain rights that are not available to others, thereby establishing an exclusivity arrangement. However, the specific terms and conditions of the exclusivity would need to be reviewed in the full text of the agreement for detailed understanding.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Can this contract be terminated for convenience, and under what conditions?",
        "response":"Yes, the contract can be terminated for convenience by Eton Pharmaceuticals, Inc. Specifically, Eton has the right to terminate the Agreement \"at its sole discretion\" after the approval of the Dossier or marketing application for the Product (or any added new product). This termination requires Eton to provide \"one hundred eighty (180) days' written notice to Aucta.\" \n\nIt is important to note that this termination right is exclusive to Eton and is contingent upon the approval of the relevant documentation.",
        "retrieved_contexts":[
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The retrieved chunk does not provide specific information regarding what happens in the event of a change of control of one of the parties in the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It only discusses the obligations of ETON after termination, including continuing to market the products and providing transition services to Aucta. Therefore, I cannot provide an answer to your question based on the provided clause.",
        "retrieved_contexts":[
            ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. The clause explicitly states that \"Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties... without the prior written consent of the other parties.\" This means that any assignment of rights or obligations under the agreement requires the written consent of the other parties involved.",
        "retrieved_contexts":[
            ".9 No Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of Law or otherwise) without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not mention any revenue or profit-sharing arrangements between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It primarily introduces the agreement and notes that certain information has been omitted for competitive reasons. Therefore, based on the information in the clause, there is no indication of revenue or profit-sharing terms included in this contract.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a minimum commitment required under this contract?",
        "response":"The provided clause does not specify any minimum commitment required under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It primarily introduces the agreement and mentions the execution date, but does not detail any terms, conditions, or commitments related to minimum obligations. Therefore, based on the information in the clause, there is no direct answer regarding a minimum commitment.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include any volume restrictions?",
        "response":"The provided clause does not mention any volume restrictions related to the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It primarily states the execution date and identifies that certain information has been omitted for competitive reasons. Therefore, based on the information in the clause, there are no details regarding volume restrictions included in this contract.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What licenses are granted under this contract?",
        "response":"The provided clause does not specify the licenses granted under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It only mentions the existence of the agreement and the date it was entered into. There are no details regarding the specific licenses or terms related to them included in the retrieved chunk. Therefore, I cannot provide an answer regarding the licenses granted under this contract based on the information available.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Are there any services to be provided after the termination of this contract?",
        "response":"Yes, after the termination of the contract, ETON is required to provide transition services to Aucta. Specifically, the clause states that ETON will assist Aucta with \"Product distribution, processing of rebates, drug safety, etc.\" This assistance is to be provided \"to the extent practicable\" after Aucta assumes control of the Product.",
        "retrieved_contexts":[
            ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What are the audit rights under this contract?",
        "response":"The retrieved chunk does not provide any information regarding the audit rights under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Therefore, I cannot answer your question based on the provided text. If you have access to additional sections of the contract, please share them for further analysis.",
        "retrieved_contexts":[
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a cap on liability under this contract?",
        "response":"The provided clause does not mention any cap on liability under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It specifies that Aucta is \"solely responsible and liable for any litigation in connection with the Product's development\" and that Eton is \"solely responsible and liable for any non-patent litigation in connection with its sales and marketing activities.\" However, there are no terms or conditions indicating a limitation or cap on that liability. Therefore, based on the clause, there is no stated cap on liability.",
        "retrieved_contexts":[
            ".1 At its sole cost and expense, Aucta shall be solely responsible and liable for any litigation in connection with the Product's development, and the Aucta Background Intellectual Property other than ANDA Litigation covered below in Section 7.5. 7.2 At its sole cost and expense, ETON shall be solely responsible and liable for any non-patent litigation in connection with its sales and marketing activities. 9"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What are the insurance requirements under this contract?",
        "response":"The insurance requirements under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. are as follows:\n\n1. **Duration of Insurance**: The parties must maintain general liability insurance from the first commercial sale of any product or after the Effective Date, continuing through five years after the final sale of such products.\n\n2. **Coverage Amounts**: The general liability insurance must be in amounts that are reasonable and customary in the pharmaceutical industry. However, it explicitly states that the insurance amounts must not be less than:\n   - **$5,000,000** per occurrence\n   - **$10,000,000** in total.\n\nThese requirements ensure that both parties are adequately covered for liabilities associated with the products during the specified time frame.",
        "retrieved_contexts":[
            ". INSURANCE At all times from the first commercial sale of any Product(s) or after the Effective Date through the date which is five (5) years after the final sale of such Product(s), the Parties will maintain general liability insurance in amounts that are reasonable and customary in the pharmaceutical industry, provided in no event shall the general liability insurance amounts be less than five million dollars ($5,000,000) per occurrence and ten million dollars ($10,000"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What is the expiration date of this contract?",
        "response":"The provided clause does not specify the expiration date of the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. It only mentions that by the fifteenth (15th) day of the last month of the Term of the Agreement, ExxonMobil will have been invoiced for charges incurred, but it does not indicate when the Term of the Agreement begins or ends. Therefore, I cannot provide the expiration date based on the information given.",
        "retrieved_contexts":[
            "i. By the fifteenth (15th) day of the last month of the Term of the Agreement, ExxonMobil will have been invoiced for the actual charges incurred in all of the prior months of the Term of the Agreement, but the most recently issued invoice will not be due. Therefore, at such time ExxonMobil will not have yet paid for the last two (2) months of the Term of the Agreement"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What is the governing law for this contract?",
        "response":"The governing law for the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells is the laws of the State of New York. This is stated in clause 13.01, which specifies that the validity and interpretation of the Agreement will be governed by New York law \"without recourse to its conflicts of law rules.\"",
        "retrieved_contexts":[
            "13.01 Governing Law. The validity and interpretation of this Agreement and the legal relations of the Parties to it will be governed by the laws of the State of New York without recourse to its conflicts of law rules."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are there any exceptions to competitive restrictions in this contract?",
        "response":"Yes, there are exceptions to the obligations of confidentiality and restricted use in the Joint Development Agreement. According to clause 4.05, these obligations do not apply to any information or materials if the Receiving Party can establish by documentary evidence that one or more exceptions apply. However, the specific exceptions are not detailed in the provided chunk. Therefore, while exceptions exist, the exact nature of those exceptions is not specified in the text you provided.",
        "retrieved_contexts":[
            "4.05 Exceptions. For the purposes of this Agreement, the obligations of confidentiality and restricted use herein shall not apply to any information or materials to the extent the Receiving Party can establish by documentary evidence that one or more of the following exceptions apply:"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there a non-compete clause in this contract?",
        "response":"The provided clause does not mention a non-compete clause. It specifically addresses the relationship between the parties, stating that they are independent contractors and clarifying that the agreement does not create a joint venture, partnership, agency, or employment relationship. There are no terms or conditions related to non-compete obligations in this clause. Therefore, based on the information given, there is no indication of a non-compete clause in the contract.",
        "retrieved_contexts":[
            "20.02 Independent Contractors. The relationship between the Parties is that of independent contractors. Nothing contained in this Agreement, or any course of action by either Party pursuant to this Agreement, will be construed or deemed to constitute or create a joint venture, partnership, agency or employment relationship between the Parties or between either Party and the employees or other representatives of the other Party."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Can this contract be terminated for convenience, and under what conditions?",
        "response":"Yes, the Joint Development Agreement can be terminated for convenience. According to the clause, either Party may terminate the Agreement or any part of a Project \"for any reason and at any time upon giving the other Party sixty (60) days prior written notice.\" This means that either party has the right to terminate the contract without needing to provide a specific reason, as long as they provide the required notice period.",
        "retrieved_contexts":[
            "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all\/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"The provided clause does not mention any rights of first refusal, rights of first offer, or rights of first negotiation. It primarily outlines various paragraphs related to independent contractors, entities, third-party beneficiaries, internal conflict, severability, amendments, integration, and execution, as well as the continuation of certain rights and obligations. Since none of these terms directly address the specific rights you inquired about, it can be concluded that the contract does not include such rights.",
        "retrieved_contexts":[
            "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The provided clause does not specifically address what happens in the event of a change of control of one of the parties in the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. It only mentions that \"any rights and obligations that have accrued to either Party against the other prior to the effective date of termination or expiration of this Agreement... will survive such termination or expiration.\" \n\nTherefore, based on the information in the clause, there is no direct answer regarding the implications of a change of control for either party.",
        "retrieved_contexts":[
            "Any rights and obligations that have accrued to either Party against the other prior to the effective date of termination or expiration of this Agreement in any respect will survive such termination or expiration, and rights that have accrued to an Affiliate of a Party will continue regardless of any change in Affiliate status during the Term of this Agreement or thereafter.\n\nARTICLE 13 - ARBITRATION AND GOVERNING LAW"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. According to the clause, \"The Agreement is not assignable... by either Party without the prior written consent of the other Party.\" This means that neither party can assign their rights or obligations under the Agreement without obtaining written consent from the other party. Additionally, any assignments not made in accordance with this provision will be considered void.",
        "retrieved_contexts":[
            "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; How is intellectual property ownership assigned in this contract?",
        "response":"The retrieved chunk does not provide specific information regarding the assignment of intellectual property ownership in the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. It only states that \"all rights and licenses granted to ExxonMobil and its Affiliates under or pursuant to this Agreement\" are considered licenses of rights to \"intellectual property\" as defined in the Bankruptcy Code. \n\nTherefore, the clause does not clarify how intellectual property ownership is assigned; it merely addresses the nature of the rights and licenses in the context of bankruptcy. For details on ownership assignment, you would need to refer to other sections of the Joint Development Agreement.",
        "retrieved_contexts":[
            "(i) All rights and licenses granted to ExxonMobil and its Affiliates under or pursuant to this Agreement are, and will otherwise be deemed to be, for all purposes of Section 365(n) of the Bankruptcy Code, licenses of rights to \"intellectual property\" as defined in section 101 of the Bankruptcy Code."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What licenses are granted under this contract?",
        "response":"The provided clause does not explicitly state the licenses granted under the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. It primarily defines what constitutes \"Background Information\" and outlines conditions related to ownership and development by the designated Party or its Affiliates.\n\nKey points from the clause include:\n\n1. Background Information is defined as being owned or controlled by the designated Party or its Affiliates, specifically in the context of having the right to license without accounting to others.\n2. It also specifies that Background Information includes items conceived, created, developed, or acquired by the designated Party or its Affiliates either prior to the Effective Date of the Agreement or independently of any Project prior to the termination of the Agreement.\n\nHowever, the clause does not provide details on the specific licenses granted under the contract. Therefore, based on the information given, I cannot provide an answer regarding the licenses granted.",
        "retrieved_contexts":[
            "(a) owned or controlled by the designated Party or its Affiliates (in the sense of having the right to license without accounting to others); and\n\n(b) conceived, created, developed, or acquired by the designated Party or its Affiliates:\n\n(1) prior to the Effective Date of this Agreement; or\n\n(2) at any time, but independently of any Project prior to the termination of this Agreement.\n\nBackground Information includes Background Samples but does not include Program Information."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are the licenses granted under this contract non-transferable?",
        "response":"The provided clause does not directly address whether the licenses granted under the Joint Development Agreement are non-transferable. It focuses on the obligations of sub-licensees regarding confidentiality and limited use of the Disclosing Party's Confidential Information. \n\nTo determine if the licenses are non-transferable, you would need to look for specific language in the agreement that explicitly states the transferability of licenses. Since this clause does not provide that information, I cannot confirm whether the licenses are non-transferable based on the retrieved chunk.",
        "retrieved_contexts":[
            ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Does the licensee's affiliates have any licensing rights under this contract?",
        "response":"The retrieved chunk does not provide specific information regarding whether the licensee's affiliates have any licensing rights under the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. It only mentions \"Disclosure to Affiliates, Contractors, and Sub-licensees,\" but does not clarify the licensing rights or conditions related to those affiliates. Therefore, based on the provided clause, it cannot be determined if the licensee's affiliates have any licensing rights under this contract.",
        "retrieved_contexts":[
            "4.06 Disclosure to Affiliates, Contractors, and Sub-licensees"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are any of the licenses granted under this contract irrevocable or perpetual?",
        "response":"The clause provided does not explicitly state that any licenses granted under the contract are irrevocable or perpetual. Instead, it specifies that in the event of termination where FCE is the defaulting party, certain royalty-free licenses will convert to royalty-bearing licenses. This conversion indicates that the licenses are not permanent and are contingent upon the status of the agreement and the actions of the parties involved.\n\nKey phrases from the clause include \"royalty-free licenses... will immediately convert to royalty-bearing licenses,\" which implies that the nature of the licenses can change based on circumstances, particularly termination due to default. Therefore, based on this clause, the licenses do not appear to be irrevocable or perpetual.",
        "retrieved_contexts":[
            ". In the event of termination under this Paragraph 12.03 where FCE is the defaulting Party, FCE's royalty-free licenses described in Paragraph 7.01(b)(1), 8.02(b)(1)(i), 8.02 (b)(1)(ii), 8.02(b)(1)(iii), and 8.02(b)(2)(i) will immediately convert to royalty-bearing licenses, with the royalty rate to be negotiated by the Parties in good faith."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are there any services to be provided after the termination of this contract?",
        "response":"The clause provided does not specify any services to be provided after the termination of the contract. It only outlines the conditions under which either party may terminate the agreement, stating that either party can terminate the agreement or any part of a project for any reason with a sixty (60) days prior written notice. \n\nTherefore, based on the information in the clause, there is no indication of any post-termination services or obligations.",
        "retrieved_contexts":[
            "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all\/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What are the audit rights under this contract?",
        "response":"The retrieved chunk does not provide specific details regarding the audit rights under the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. It only mentions \"18.02 Audit Rights\" without elaborating on the terms, conditions, or restrictions associated with those rights. Therefore, I cannot provide a direct answer regarding the audit rights as the necessary information is not included in the provided text.",
        "retrieved_contexts":[
            "18.02 Audit Rights"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there uncapped liability under this contract?",
        "response":"The clause provided states that \"In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage.\" This indicates that there are limitations on liability for certain types of damages. \n\nHowever, the clause does not explicitly mention whether there is any uncapped liability for other types of damages or claims that may arise under the agreement. Therefore, based on the information in the clause, it cannot be determined if there is uncapped liability under the contract, as the clause only addresses limitations on specific types of losses and damages. \n\nIn summary, the clause limits liability for certain damages but does not provide a clear answer regarding uncapped liability for other potential claims.",
        "retrieved_contexts":[
            ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there a cap on liability under this contract?",
        "response":"The provided clause does not explicitly mention a cap on liability under the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. Instead, it states that \"in no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage.\" This indicates that certain types of damages are excluded from liability, but it does not specify a monetary cap or limit on liability for other types of damages. Therefore, based on the clause, there is no clear cap on liability stated in the agreement.",
        "retrieved_contexts":[
            ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; What is the expiration date of this contract?",
        "response":"The provided clause does not specify an expiration date for the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. Therefore, based on the information available in the clause, there is no direct answer regarding the expiration date of the contract.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. Therefore, based on the information given, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not explicitly mention an exclusivity agreement between Reed's, Inc. and B C Marketing Concepts Inc. It only states that Reed's desires to engage the Company to assist in the development of formulas for ginger-based flavored alcohol beverage products. There are no terms, conditions, or restrictions related to exclusivity included in the retrieved chunk. Therefore, based on the information provided, it cannot be concluded that the contract includes an exclusivity agreement.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there an anti-assignment clause in this contract?",
        "response":"The retrieved chunk does not explicitly mention an anti-assignment clause. However, it does state that \"Neither party shall have the right to bind the other party to any obligations to third parties.\" This implies a restriction on the ability to assign obligations or rights to third parties without consent. \n\nIf you are looking for a specific anti-assignment clause, it is not directly provided in the text you shared. Therefore, based on the information available, it cannot be confirmed that there is a formal anti-assignment clause in the contract.",
        "retrieved_contexts":[
            ". This Agreement does not constitute and shall not be construed as constituting a partnership or joint venture or grant of a franchise between Reed's and Company. Neither party shall have the right to bind the other party to any obligations to third parties. 13. Assignment"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; How is intellectual property ownership assigned in this contract?",
        "response":"The provided clause does not explicitly address the assignment of intellectual property ownership in the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. It only defines \"Company Intellectual Property\" as including the company's know-how, independently developed recipes, and production processes, specifically mentioning the proprietary composition of the neutral alcohol beverage base.\n\nTo determine how intellectual property ownership is assigned in the contract, you would need to refer to the specific terms of the Recipe Development Agreement itself, as the clause does not provide that information.",
        "retrieved_contexts":[
            ". Company Intellectual Property includes but is not limited to Company's know-how and independently developed recipes and alcohol beverage production processes, including the Company's proprietary composition of or recipe for the neutral alcohol beverage base that contributes alcohol to the Products (\"Neutral Alcohol Beverage Base\")"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there uncapped liability under this contract?",
        "response":"The provided clause does not address liability, whether capped or uncapped, under the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. It specifically focuses on the disclosure of Intellectual Property related to the Products and outlines exceptions regarding the Neutral Alcohol Beverage Base and the Company's general know-how. \n\nTo determine if there is uncapped liability, you would need to refer to other sections of the contract that specifically discuss liability terms, limitations, or caps. The current clause does not provide that information.",
        "retrieved_contexts":[
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there a cap on liability under this contract?",
        "response":"The provided clause does not address liability or any cap on liability under the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. It specifically discusses the disclosure obligations related to Intellectual Property but does not mention any terms regarding liability or limitations thereof. Therefore, based on the information in the clause, there is no indication of a cap on liability in this contract.",
        "retrieved_contexts":[
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there a covenant not to sue included in this contract?",
        "response":"The provided clause does not mention a covenant not to sue. It primarily outlines the engagement between Reed's and Company for the development of formulas for ginger-based flavored alcohol beverage products. There are no terms, conditions, or restrictions related to a covenant not to sue included in the retrieved chunk. Therefore, based on the information available, it can be concluded that there is no covenant not to sue in this contract.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the expiration date of this contract?",
        "response":"The provided clause does not specify the expiration date of the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. It only includes the date of the agreement (29\/3\/18) and the parties involved. Therefore, I cannot provide an expiration date based on the information given.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the renewal term for this contract?",
        "response":"The provided clause does not specify any details regarding the renewal term for the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. Therefore, I cannot provide an answer regarding the renewal term as it is not stated in the retrieved chunk.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the notice period required to terminate the renewal?",
        "response":"The clause does not specify a notice period required to terminate the renewal of the Distributorship Agreement. It only mentions that the Distributor has the option to renew the Agreement for an additional three-year period by providing prior written notice to the Company within ninety (90) days of the end of the initial period. However, it does not outline any conditions or requirements for terminating the renewal once it has been established. Therefore, based on the provided clause, there is no clear information regarding the notice period for terminating the renewal.",
        "retrieved_contexts":[
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. Therefore, I cannot provide an answer regarding the governing law based on the information in the clause.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Is there an anti-assignment clause in this contract?",
        "response":"The provided chunk does not contain any information regarding an anti-assignment clause in the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. The text primarily includes the date of the agreement, the parties involved, and their addresses, but does not specify any terms, conditions, or restrictions related to assignment of rights or obligations under the contract. Therefore, based on the retrieved information, I cannot confirm the presence of an anti-assignment clause.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What licenses are granted under this contract?",
        "response":"The provided clause does not specify any details regarding the licenses granted under the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. It only includes basic information about the parties involved and the date of the agreement. Therefore, I cannot provide an answer regarding the specific licenses granted under this contract as that information is not included in the retrieved chunk.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Are there any services to be provided after the termination of this contract?",
        "response":"The retrieved chunk does not provide any information regarding services to be provided after the termination of the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. It only includes the parties involved and the background of the agreement. Therefore, based on the provided clause, there is no mention of post-termination services.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What are the insurance requirements under this contract?",
        "response":"The provided clause does not include any information regarding the insurance requirements under the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. Therefore, I cannot provide details about the insurance requirements as they are not stated in the retrieved chunk.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Is there a covenant not to sue included in this contract?",
        "response":"The provided clause does not contain any information regarding a covenant not to sue. It only includes the parties involved in the Distributorship Agreement and their respective addresses. There are no terms, conditions, or restrictions mentioned that would indicate the presence of a covenant not to sue. Therefore, based on the information available in the retrieved chunk, there is no indication of such a covenant in this contract.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not specify an expiration date for the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor. It only states that the Agreement is effective as of August 1, 2019. Therefore, without additional information from the full contract, I cannot provide an expiration date.",
        "retrieved_contexts":[
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the renewal term for this contract?",
        "response":"The renewal term for the Distributor Agreement is an additional Three (3) year period. The Distributor has the option to renew the Agreement by providing prior written notice to the Company within Ninety (90) days of the end of the initial three-year period.",
        "retrieved_contexts":[
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor for Coffee Products. It focuses on the rights, authority, and legal standing of the parties involved but does not mention any governing law or jurisdiction. Therefore, based on the information in the clause, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a most favored nation clause in this contract?",
        "response":"The retrieved chunk indicates that the contract does not grant \"most favored nation\" rights, except for provisions that are not material to the Company and its Subsidiaries. Therefore, if the Distributor Agreement contains a \"most favored nation\" clause, it would not be applicable unless it meets the criteria of being immaterial to the Company and its Subsidiaries as a whole. \n\nIn summary, the clause suggests that there are no significant \"most favored nation\" rights in the agreement unless they are deemed immaterial.",
        "retrieved_contexts":[
            ", (C) contains any provision that requires the purchase of all or any portion of the Company\u2019s or any of its Subsidiaries\u2019 requirements from any Third Party or (D) grants \u201cmost favored nation\u201d rights, except in the case of each of clauses (A), (B), (C) and (D) for such rights and provisions that are not material to the Company and its Subsidiaries, taken as a whole"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Does this contract include an exclusivity agreement?",
        "response":"Yes, the contract includes an exclusivity agreement. The clause states that the Company \"hereby appoints and grants Distributor the exclusive right to sell and distribute the Products\" within the territory of the United States of America. This exclusivity is subject to the terms and conditions of the Distributor Agreement, meaning that the Distributor has the sole right to sell and distribute the specified products to customers that they introduce and confirm with the Company.",
        "retrieved_contexts":[
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a clause preventing the solicitation of customers in this contract?",
        "response":"Yes, there is a clause preventing the solicitation of customers in the contract. The clause states, \"The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor.\" This clearly indicates that the Company is prohibited from contacting the Distributor's customers unless they have received prior written approval from the Distributor.",
        "retrieved_contexts":[
            ". The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor."
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. According to clause 16.1, \"The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement.\" This indicates that the Distributor is generally prohibited from assigning or transferring the agreement without consent. However, there is an exception that allows the Distributor to assign or transfer the agreement to a \"Permitted Assignee\" without the consent of the Supplier.",
        "retrieved_contexts":[
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Are there any price restrictions or controls specified in this contract?",
        "response":"The clause clearly states that \"Distributor shall be free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion.\" This indicates that there are no price restrictions or controls specified in the contract. Additionally, it mentions that \"Company shall have no control over or any liability in connection with the price at which Distributor resells the Products,\" further confirming that the Distributor has complete discretion over pricing. Therefore, there are no restrictions or controls on pricing in this agreement.",
        "retrieved_contexts":[
            ". Distributor shall be free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion. Company shall have no control over or any liability in connection with the price at which Distributor resells the Products, and Distributor shall hold Company harmless and indemnify and defend Company from and against any liability resulting therefrom. 3. REPRESENTATIONS"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Does this contract include any volume restrictions?",
        "response":"The provided clause does not contain any information regarding volume restrictions related to the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor for Coffee Products. It only states the parties involved and the effective date of the agreement. Therefore, based on the retrieved chunk, there is no mention of any volume restrictions in the contract.",
        "retrieved_contexts":[
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; How is intellectual property ownership assigned in this contract?",
        "response":"In the Distributor Agreement, the ownership of intellectual property, specifically trademarks, is assigned as follows: The Distributor is prohibited from initiating any legal proceedings regarding the trademarks of the Company without obtaining \"express written permission\" from the Company. Furthermore, any rights in the trademarks that may benefit the Distributor must be assigned to the Company \"without charge.\" \n\nAdditionally, the Distributor is required to execute any necessary documents or take any actions needed to fulfill the intent of this section. This indicates that the Company retains ownership of its trademarks, while the Distributor must comply with the Company's directives regarding those trademarks.",
        "retrieved_contexts":[
            ". Distributor will not institute any proceedings with respect to the trademarks of Company either in Distributor's own name or on behalf of Company without express written permission of Company. Distributor shall assign to Company, without charge, any rights in the trademarks of Company that may inure to the benefit of Distributor pursuant to this Agreement or otherwise. Distributor shall execute any documents or do any acts that may be required to accomplish the intent of this Section. 12"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Are there any services to be provided after the termination of this contract?",
        "response":"According to the clause provided, after the termination of the Distributor Agreement, the Company has no further responsibilities to the Distributor, except in specific circumstances. If the Agreement is terminated for any reason other than a breach by the Distributor, the Company is obligated to process orders that were accepted prior to the effective date of termination or within ninety (90) days thereafter. \n\nTherefore, the only service that will be provided after termination is the processing of those accepted orders, and this obligation is contingent on the termination not being due to a breach by the Distributor.",
        "retrieved_contexts":[
            ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a cap on liability under this contract?",
        "response":"The retrieved clause does not explicitly mention a cap on liability under the Distributor Agreement. It states that liability is excluded \"except to the extent the liability arises as a result of the wilful misconduct of the Distributor.\" This implies that if the Distributor engages in wilful misconduct, they may be held liable without limitation. Therefore, based on the provided clause, there does not appear to be a cap on liability; rather, liability may be fully applicable in cases of wilful misconduct.",
        "retrieved_contexts":[
            ", except to the extent the liability arises as a result of the wilful misconduct of the Distributor"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the duration of any warranties provided in this contract?",
        "response":"The provided clause does not specify any information regarding the duration of warranties in the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor. Therefore, I cannot provide an answer about the duration of any warranties as it is not stated in the retrieved chunk.",
        "retrieved_contexts":[
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a covenant not to sue included in this contract?",
        "response":"The provided clause does not explicitly mention a covenant not to sue. It primarily addresses the Company's rights and authority to enter into the Agreement, the compliance with other agreements, and the absence of pending litigation that could interfere with the Agreement's performance. \n\nKey phrases from the clause include: \"Company has all rights, power, and authority to enter into this Agreement\" and \"Neither Party is subject to any pending or threatened litigation.\" However, there is no indication of a covenant not to sue included in this contract. Therefore, based on the information provided, there is no covenant not to sue in the Distributor Agreement.",
        "retrieved_contexts":[
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology for Cryptocurrency Mining Rigs; What is the expiration date of this contract?",
        "response":"The provided clause does not specify an expiration date for the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology. Therefore, based on the information given, I cannot provide a direct answer regarding the expiration date of the contract.",
        "retrieved_contexts":[
            "EXHIBIT 10.5 NON-EXCLUSIVE DISTRIBUTOR AGREEMENT This Non-Exclusive Distributor Agreement (the \"Agreement\") is made and entered into as of this 19th day of July 2018, by and between iMine Corporation, (hereinafter referred to as \"JRVS\") and SUNWAI Technology, a Taiwanese company, with its principal office at 6th Floor, No. 258, Section 3, Nanjing East Road, Songshan District, Taipei 10051 (hereinafter referred to as the \"Distributor\")"
        ]
    },
    {
        "user_input":"Consider the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology for Cryptocurrency Mining Rigs; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology for Cryptocurrency Mining Rigs. It only outlines the desire of the Distributor to be a nonexclusive distributor and the intention of JRVS to sell its products through the Distributor. Therefore, based on the information given, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ". RECITAL WHEREAS, Distributor desires to be, a nonexclusive distributor of JRVS for certain cryptocurrency mining rig products; JRVS wishes to sell its products through Distributor on a continuing basis on the terms and conditions set forth below. AGREEMENT NOW, THEREFORE, in consideration of the mutual agreements and covenants, JRVS and the Distributor agree as follows: 1. DEFINITIONS 1"
        ]
    }
]